Vertex Pharmaceuticals (VRTX)

Vertex Pharmaceuticals Financial Statements


Vertex Pharmaceuticals Financial Overview

Vertex Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $12.364; its P/E ratio is 23.42; Vertex Pharmaceuticals is scheduled to report earnings on November 2, 2022, and the estimated EPS forecast is $3.62. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement
Total Revenue$ 2.20B$ 2.10B$ 2.07B$ 1.98B$ 1.79B
Gross Profit$ 1.93B$ 1.85B$ 1.83B$ 1.75B$ 1.57B
EBIT$ 1.04B$ 969.70M$ 886.04M$ 1.10B$ -28.78M
EBITDA$ 1.08B$ 1.01B$ 919.88M$ 1.13B$ 2.50M
Net Income Common Stockholders$ 810.50M$ 762.10M$ 770.11M$ 851.93M$ 66.92M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 9.25B$ 8.24B$ 7.52B$ 6.96B$ 6.71B
Total Assets$ 15.58B$ 14.26B$ 13.43B$ 12.62B$ 12.22B
Total Debt$ 588.91M$ 894.20M$ 872.50M$ 876.80M$ 887.20M
Net Debt$ -8.66B$ -7.34B$ -6.65B$ -6.08B$ -5.82B
Total Liabilities$ 3.65B$ 3.35B$ 3.33B$ 3.09B$ 3.03B
Stockholders Equity$ 11.93B$ 10.91B$ 10.10B$ 9.53B$ 9.20B
Cash Flow
Free Cash Flow$ 1.09B$ 892.60M$ 933.28M$ 874.70M$ -249.57M
Operating Cash Flow$ 1.14B$ 956.20M$ 994.99M$ 927.22M$ -199.71M
Investing Cash Flow$ -61.50M$ -51.00M$ -134.00M$ -52.95M$ -79.65M
Financing Cash Flow$ 47.70M$ -95.40M$ -336.24M$ -656.66M$ 33.60M
Currency in USD

Vertex Pharmaceuticals Earnings and Revenue History

Vertex Pharmaceuticals Debt to Assets

Vertex Pharmaceuticals Cash Flow

Vertex Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis